Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METHYLENEDIOXYPYROVALERONE Cause Vestibular disorder? 12 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Vestibular disorder have been filed in association with METHYLENEDIOXYPYROVALERONE. This represents 7.6% of all adverse event reports for METHYLENEDIOXYPYROVALERONE.

12
Reports of Vestibular disorder with METHYLENEDIOXYPYROVALERONE
7.6%
of all METHYLENEDIOXYPYROVALERONE reports
0
Deaths
0
Hospitalizations

How Dangerous Is Vestibular disorder From METHYLENEDIOXYPYROVALERONE?

Of the 12 reports.

Is Vestibular disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METHYLENEDIOXYPYROVALERONE. However, 12 reports have been filed with the FAERS database.

What Other Side Effects Does METHYLENEDIOXYPYROVALERONE Cause?

Toxicity to various agents (154) Aggression (40) Logorrhoea (37) Abnormal behaviour (32) Dysarthria (31) Memory impairment (29) Confusional state (19) Coordination abnormal (19) Disturbance in attention (19) Restlessness (19)

What Other Drugs Cause Vestibular disorder?

GENTAMICIN (57) ADALIMUMAB (30) DIAZEPAM (25) MORPHINE (25) MIRTAZAPINE (24) VANCOMYCIN (22) LINEZOLID (21) CODEINE (20) AMIODARONE (19) PREGABALIN (19)

Which METHYLENEDIOXYPYROVALERONE Alternatives Have Lower Vestibular disorder Risk?

METHYLENEDIOXYPYROVALERONE vs METHYLERGONOVINE METHYLENEDIOXYPYROVALERONE vs METHYLNALTREXONE METHYLENEDIOXYPYROVALERONE vs METHYLPHENIDATE METHYLENEDIOXYPYROVALERONE vs METHYLPREDNISOLONE METHYLENEDIOXYPYROVALERONE vs METHYLPREDNISOLONE ACEPONATE

Related Pages

METHYLENEDIOXYPYROVALERONE Full Profile All Vestibular disorder Reports All Drugs Causing Vestibular disorder METHYLENEDIOXYPYROVALERONE Demographics